Study S002657

A Randomized Pilot Study Evaluating Combination Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Plus Metformin Compared to Metformin Monotherapy and Placebo on Metabolic Abnormalities in Women With a Recent History of GDM

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT01856907
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: COMPLETED
Enrollment: 36
Start: 2013-09-28
Primary completion: 2017-09-05
Lead sponsor: Woman's
Conditions: Disorder of Glucose Regulation
Interventions: DRUG:Sitagliptin-Metformin; DRUG:Metformin; DRUG:Placebo pill
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Normalization of Glucose Levels [16 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.